(Q36728061)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17278059%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Mutant selection window hypothesis updated (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17278059%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17278059%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Karl Drlica

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17278059%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

24 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17278059%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17278059%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17278059%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

681-688

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17278059%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17278059%20AND%20SRC:MED&resulttype=core&format=json

Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies

25 December 2019

cites work

1 reference

Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window

21 January 2018

1 reference

Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance

21 January 2018

1 reference

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherap

21 January 2018

1 reference

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

21 January 2018

1 reference

Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.

21 January 2018

1 reference

Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria

21 January 2018

1 reference

Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa

21 January 2018

1 reference

Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus

21 January 2018

1 reference

Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.

21 January 2018

1 reference

Resistance to antibiotics mediated by target alterations

21 January 2018

1 reference

Resistance to beta-lactam antibiotics

21 January 2018

1 reference

Mutation prevention concentration of ceftriaxone, meropenem, imipenem, and ertapenem against three strains of Streptococcus pneumoniae

21 January 2018

1 reference

Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis

21 January 2018

1 reference

Effect of Rifampin on Nasal Carriage of Staphylococcus aureus

21 January 2018

1 reference

Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli

21 January 2018

1 reference

Low correlation between MIC and mutant prevention concentration

21 January 2018

1 reference

Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus

21 January 2018

1 reference

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

21 January 2018

1 reference

Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.

21 January 2018

1 reference

The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration

21 January 2018

1 reference

In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.

21 January 2018

1 reference

Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing

21 January 2018

1 reference

Pharmacodynamic modeling of the evolution of levofloxacin resistance in Staphylococcus aureus

21 January 2018

1 reference

Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments

21 January 2018

1 reference

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

21 January 2018

1 reference

Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.

21 January 2018

1 reference

Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models

21 January 2018

1 reference

Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits.

21 January 2018

1 reference

In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.

21 January 2018

1 reference

The mutant selection window in rabbits infected with Staphylococcus aureus.

21 January 2018

1 reference

Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance

21 January 2018

1 reference

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

21 January 2018

1 reference

Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin

21 January 2018

1 reference

Mobile gene cassettes: a fundamental resource for bacterial evolution

21 January 2018

1 reference

The role of mutators in the emergence of antibiotic-resistant bacteria

21 January 2018

1 reference

Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections

21 January 2018

1 reference

Staphylococcus aureus mutants selected by BMS-284756.

21 January 2018

1 reference

Activity of the novel des-fluoro(6) quinolone BMS-284756 against methicillin-susceptible and -resistant staphylococci

21 January 2018

1 reference

Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci

21 January 2018

1 reference

The in vitro activity of BMS-284756, a new des-fluorinated quinolone

21 January 2018

1 reference

Trends in bacterial resistance to fluoroquinolones

21 January 2018

1 reference

Fluoroquinolones as pneumococcal therapy: closing the barn door before the horse escapes

21 January 2018

1 reference

Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus.

21 January 2018

1 reference

Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects

21 January 2018

1 reference

The mutant selection window and antimicrobial resistance

21 January 2018

1 reference

ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model

21 January 2018

1 reference

Concentration-dependent changes in the susceptibility and killing of Staphylococcus aureus in an in vitro dynamic model that simulates normal and impaired gatifloxacin elimination.

21 January 2018

1 reference

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

21 January 2018

1 reference

Low-level antibacterial resistance: a gateway to clinical resistance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/511642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17278059%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference